ATE322685T1 - Verfahren zum erlangen von rezeptor- freigabeligand (reland)-komplexen und testansätze - Google Patents

Verfahren zum erlangen von rezeptor- freigabeligand (reland)-komplexen und testansätze

Info

Publication number
ATE322685T1
ATE322685T1 AT96923333T AT96923333T ATE322685T1 AT E322685 T1 ATE322685 T1 AT E322685T1 AT 96923333 T AT96923333 T AT 96923333T AT 96923333 T AT96923333 T AT 96923333T AT E322685 T1 ATE322685 T1 AT E322685T1
Authority
AT
Austria
Prior art keywords
reland
receptor
analyte
complexes
testing approaches
Prior art date
Application number
AT96923333T
Other languages
English (en)
Inventor
Judith Fitzpatrick
Regina Lenda
Original Assignee
Serex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serex Inc filed Critical Serex Inc
Application granted granted Critical
Publication of ATE322685T1 publication Critical patent/ATE322685T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT96923333T 1995-06-22 1996-06-19 Verfahren zum erlangen von rezeptor- freigabeligand (reland)-komplexen und testansätze ATE322685T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/493,420 US5710009A (en) 1994-02-17 1995-06-22 Receptor:release ligand (reland) complexes and release assays using said reland and methods and kits based thereon

Publications (1)

Publication Number Publication Date
ATE322685T1 true ATE322685T1 (de) 2006-04-15

Family

ID=23960154

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96923333T ATE322685T1 (de) 1995-06-22 1996-06-19 Verfahren zum erlangen von rezeptor- freigabeligand (reland)-komplexen und testansätze

Country Status (9)

Country Link
US (1) US5710009A (de)
EP (1) EP0840895B1 (de)
JP (1) JP3103379B2 (de)
AT (1) ATE322685T1 (de)
AU (1) AU6387596A (de)
CA (1) CA2225210C (de)
DE (1) DE69636013T2 (de)
ES (1) ES2265646T3 (de)
WO (1) WO1997001097A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01155293U (de) * 1988-04-15 1989-10-25
FI100276B (fi) * 1996-02-06 1997-10-31 Orion Yhtymae Oy Menetelmä analyyttien ei-kilpailevaa määritystä varten
US20020131972A1 (en) * 1998-05-21 2002-09-19 Daniel Sem Multi-partite ligands and methods of identifying and using same
DE69917258T2 (de) 1998-06-01 2005-07-14 Roche Diagnostics Corp., Indianapolis Methode und vorrichtung zum elektrochemischen immunoassay mehrerer analyten
US7166475B2 (en) * 1999-02-26 2007-01-23 Cyclacel Ltd. Compositions and methods for monitoring the modification state of a pair of polypeptides
JP2002539458A (ja) * 1999-03-16 2002-11-19 セレックス， インコーポレイテッド 唾液中のａｐｏａおよびａｐｏｂ、ならびにそれらの比を検出するための方法およびデバイス
US6699722B2 (en) 2000-04-14 2004-03-02 A-Fem Medical Corporation Positive detection lateral-flow apparatus and method for small and large analytes
EP1420641A4 (de) * 2001-08-01 2005-05-25 Anil K Chauhan Immunkomplexe
US7653490B2 (en) * 2001-09-10 2010-01-26 Triad Liquidating Company LLC Nuclear magnetic resonance assembly of chemical entities
US20030180797A1 (en) * 2002-03-20 2003-09-25 Lin Yu Identification of ligands for a receptor family and related methods
US20040208865A1 (en) * 2003-02-12 2004-10-21 Chauhan Anil K. Immune complexes
WO2010009459A1 (en) * 2008-07-18 2010-01-21 Bayer Healthcare Llc Methods, devices, and systems for glycated hemoglobin analysis
CN102126862B (zh) * 2010-01-12 2012-10-10 宝山钢铁股份有限公司 一种焦炉炭化室炉墙涂层材料及其使用方法
EP2686680B1 (de) * 2011-03-18 2018-06-13 Biotium Inc. Fluoreszierende farbstoffe, fluoreszenzfarbstoffkits und verfahren zur herstellung von markierter moleküle
US11422136B2 (en) * 2017-10-19 2022-08-23 Idexx Laboratories, Inc. Detection of symmetrical dimethylarginine

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US4069105A (en) * 1977-03-03 1978-01-17 Syva Company Lidocaine antigens and antibodies
US4318707A (en) * 1978-11-24 1982-03-09 Syva Company Macromolecular fluorescent quencher particle in specific receptor assays
US4323507A (en) * 1979-02-12 1982-04-06 Syva Company Valproate conjugation using dicarbonyls
US4341866A (en) * 1980-06-02 1982-07-27 Syva Company Antienzyme termination in enzyme immunoassays
GB2078370A (en) * 1980-06-13 1982-01-06 Nat Res Dev Binding assays
US4590278A (en) * 1981-01-29 1986-05-20 Philip Morris Incorporated Nicotine analogs
US4533493A (en) * 1981-08-27 1985-08-06 Miles Laboratories, Inc. Theophylline immunogens, antibodies, labeled conjugates, and related derivatives
US4480042A (en) * 1981-10-28 1984-10-30 E. I. Du Pont De Nemours And Company Covalently bonded high refractive index particle reagents and their use in light scattering immunoassays
US4434236A (en) * 1982-10-20 1984-02-28 E. I. Du Pont De Nemours & Co. Immunoassay wherein labeled antibody is displaced from immobilized analyte-analogue
US4504412A (en) * 1983-02-07 1985-03-12 National Distillers And Chemical Corporation Cyclohexane derivatives in fragrance compositions
US4551426A (en) * 1983-10-03 1985-11-05 E. I. Du Pont De Nemours And Company Heterogeneous immunoassay for digoxin using ouabain as a separation means
US4766064A (en) * 1984-05-07 1988-08-23 Allied Corporation Displacement polynucleotide assay employing polyether and diagnostic kit
US4977077A (en) * 1984-10-24 1990-12-11 Bioprobe International Integrated solid-phase immunoassay
JPH0750114B2 (ja) * 1986-03-17 1995-05-31 富士写真フイルム株式会社 免疫分析器具を用いる分析方法
US5137808A (en) * 1987-04-07 1992-08-11 Syntex (U.S.A.) Inc. Immunoassay device
US5009998A (en) * 1987-06-26 1991-04-23 E. I. Du Pont De Nemours And Company Method for performing heterogeneous immunoassay
DE3922960A1 (de) * 1989-07-12 1991-01-17 Boehringer Mannheim Gmbh Verfahren zur bestimmung eines analyten
US5183740A (en) * 1990-02-23 1993-02-02 The United States Of America As Represented By The Secretary Of The Navy Flow immunosensor method and apparatus
US5164504A (en) * 1991-01-16 1992-11-17 Abbott Laboratories Haptens, tracers, immunogens and antibodies for immunoassays for cotinine derivatives
EP0600936B1 (de) * 1991-07-29 1999-10-06 Serex, Inc. Differentielle bindungsaffinitäten und darauf beruhende dissoziationstestverfahren
WO1995016026A1 (en) * 1993-12-10 1995-06-15 Abbott Laboratories Reagents and methods for the detection of methotrexate

Also Published As

Publication number Publication date
CA2225210C (en) 2004-02-17
JP3103379B2 (ja) 2000-10-30
EP0840895A1 (de) 1998-05-13
EP0840895A4 (de) 2000-04-26
JPH10511776A (ja) 1998-11-10
US5710009A (en) 1998-01-20
AU6387596A (en) 1997-01-22
WO1997001097A1 (en) 1997-01-09
CA2225210A1 (en) 1997-01-09
DE69636013T2 (de) 2007-04-12
DE69636013D1 (de) 2006-05-18
ES2265646T3 (es) 2007-02-16
EP0840895B1 (de) 2006-04-05

Similar Documents

Publication Publication Date Title
ATE322685T1 (de) Verfahren zum erlangen von rezeptor- freigabeligand (reland)-komplexen und testansätze
ATE99060T1 (de) Testverfahren und reagenzsatz dazu.
ES8400199A1 (es) Procedimiento para la produccion de dispositivos de analisis inmunologicos.
DE69516007D1 (de) Verfahren zum nachweiss von antikörpern
ATE185424T1 (de) Differentielle bindungsaffinitäten und darauf beruhende dissoziationstestverfahren
DK0895592T3 (da) Biosensoranordning og fremgangsmåde
IL101233A (en) Receptor-based screening and identifying methods for amylin agonists and antagonists
AU7727491A (en) Improvements in or relating to methods for providing internal references for use in analyte-receptor assays
ATE208900T1 (de) Verringerung des hook-effekts in immuntests mit teilchenförmigem trägermaterial
MX9604183A (es) Metodo de examen para identificar ligandos para proteinas objetivo.
ATE172541T1 (de) Verfahren zum nachweis biologischer wechselwirkungen, insbesondere in rezeptorbindungs-assays
HUT65621A (en) Method for determination of concentration variants and compositions and test kits for use in such methods
DK0402997T3 (da) Fremgangsmåde til bestemmelse af nukleinsyre
SE9502024D0 (sv) Pathogen assay method
KR950701075A (ko) 생물학적 유체내 리간드의 양을 측정하는 방법 및 이를 수행하기 위한 키트(Method for determination of the amount of a ligand in a biololgical fluid and kit for carrying out such a method)
AU3996693A (en) Process for the immunochemical determination of an analyte
DE69222991T2 (de) Immunoassay für freie Analyten
DE69015056D1 (de) Trennung von Antikörpern gegen Metallchelate.
ATE196009T1 (de) Verfahren und vorrichtung zur gewinnung und zum nachweis von immunologisch aktiven substanzen aus der gasphase

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0840895

Country of ref document: EP

REN Ceased due to non-payment of the annual fee